Walgreens (WBA) launches next-day prescription delivery with FedEx

NASDAQ: WBA | Walgreens Boots Alliance, Inc. News, Ratings, and Charts

WBA – Walgreens is working with FedEx to launch a nationwide next-day delivery service for prescription drugs as the top pharmacy chains gear up to compete with Amazon.

Walgreens is working with FedEx to launch a nationwide next-day delivery service for prescription drugs as the top pharmacy chains gear up to compete with Amazon.

Amazon bought online pharmacy PillPack in June, but the deal has not closed yet, giving Walgreens and its rivals the chance to head off a possible disruption in the pharmacy space.

Even before the e-commerce giant announced the acquisition, pharmacies had anticipated that Amazon would branch out into delivering prescription drugs. Competitor CVS rolled out its own delivery service for prescription drugs in June, just days before the deal.

Walgreens already offers same-day delivery in select markets, and the pharmacy chain will continue to expand that program next year.

The delivery service is part of Walgreens Express, which also lets customers preview the cost of their prescriptions and prepay for those that are eligible. Patients can pay $4.99 to have their qualifying prescription drug delivered as early as the next day or choose to pick it up in stores, checking out in a special express line.

“Next-day prescription home delivery is another convenience-driver, alongside our industry-leading number of extended hours pharmacies and one of the most downloaded digital apps in the category, designed to put care in the hands of our patients,” Richard Ashworth, president of operations for Walgreens, said in a statement.

Walgreens and FedEx have already partnered to let customers pick up and drop off packages at almost 8,000 pharmacies nationwide.


Walgreens Boots Alliance Inc. shares were trading at $82.07 per share on Thursday afternoon, down $0.75 (-0.91%). Year-to-date, WBA has gained 15.72%, versus a 1.08% rise in the benchmark S&P 500 index during the same period.

WBA currently has a StockNews.com POWR Rating of A (Strong Buy), and is ranked #1 of 4 stocks in the Medical – Drug Stores category.


This article is brought to you courtesy of CNBC.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NYSE: CMG | Chipotle Mexican Grill, Inc. Common Stock News, Ratings, and Charts

Chipotle (CMG) reports earnings, tops expectations

The chain’s stock has soared 63% so far in 2019.
NASDAQ: FB | Facebook, Inc. - Class A Common Stock News, Ratings, and Charts

Facebook (FB) reports Q1 earnings, shares surge

Facebook Inc. shares jumped in late trading Wednesday.
NASDAQ: MSFT | Microsoft Corporation News, Ratings, and Charts

Microsoft (MSFT) reports Q3 earnings, shares move higher

Microsoft reported fiscal Q3 2019 earnings on Wednesday, and the stock jumped 2 percent on better-than-expected revenue.
NYSE: CAT | Caterpillar, Inc. Common Stock News, Ratings, and Charts

Caterpillar (CAT) reports earnings, shares slide

Caterpillar Inc spooked investors for a second straight quarter.
NYSE: TWTR | Twitter, Inc. Common Stock News, Ratings, and Charts

Trump met with Twitter (TWTR) CEO Jack Dorsey at the White House

Trump held a closed-door meeting with Twitter co-founder Jack Dorsey at the White House on Tuesday evening to discuss the social media platform.

Read More Stories


More Walgreens Boots Alliance, Inc. (WBA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All WBA News
Page generated in 1.1556 seconds.